ESR1 and endometrial cancer: Jing et al. revealed that under the action of ERα agonists, ERα+ M2 macrophages significantly up-regulated CCL18 and activated the mTOR/KIF5B signaling pathway in endometrial cancer cells to promote EMT [101].